Effects of high-fat high-sucrose feeding, energy restriction, and trans-10, cis-12 conjugated linoleic acid on visfatin and apelin in hamsters

Journal of the American College of Nutrition

Volumn 28, Issue 6, 2009, Pages 627-635

  Portillo, María Puy ^a   Lasa, Arrate ^a   Churruca, Itziar ^a   Simón, Edurne ^a   Macarulla, María Teresa ^a   Fernández Quintela, Alfredo ^a   Rodríguez, Víctor M ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Apelin; Conjugated linoleic acid; Energy restriction; Hamster; High fat high sucrose feeding; Visfatin

Indexed keywords

CARRIER PROTEIN; INSULIN; LEPTIN; LINOLEIC ACID; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT INTAKE; GENETICS; HAMSTER; INSULIN RESISTANCE; MALE; METABOLISM; PHYSIOLOGY; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUGAR INTAKE; SYRIAN HAMSTER;

ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; CARRIER PROTEINS; CRICETINAE; DIETARY FATS; DIETARY SUCROSE; ENZYME-LINKED IMMUNOSORBENT ASSAY; INSULIN; INSULIN RESISTANCE; LEPTIN; LINOLEIC ACID; MALE; MESOCRICETUS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PPAR GAMMA; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77955905594     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2009.10719795     Document Type: Article

References (51)

1. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430, 2005.
2. Sommer G, Garten A, Petzold S, Beck-Sickinger A, Bluher M, Stumvoll M, Fasshauer M: Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond) 115:13-23, 2008.
3. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I: Retraction. Science 318:565, 2007.
4. Revollo J, Korner A, Mills K, Satoh A, Wang T, Garten A, Dasgupta B, Sasaki Y, Wolberger C, Townsend R, Milbrandt J, Kiess W, Imai S: Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 6:363-375, 2007.
5. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpéne C, Audigier Y, Saulnier-Blache J, Valet P: Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146:1764-1771, 2005.
6. Carpeéneé C, Dray C, Attaneé C, Valet P, Portillo M, Churruca I, Milagro F, Castan-Laurell I: Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 63:359-373, 2007.
7. Higuchi K, Masaki T, Gotoh K, Chiba S, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H: Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 148:2690-2697, 2007.
8. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleéon M, Cani PD, Attaneé C, Guigneé C, Carpeéneé C, Burcelin R, Castan- Laurell I, Valet P: Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8:437-445, 2008.
9. Reeves PG, Nielsen FH, Fahey GC Jr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951, 1993.
10. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985.
11. Livak K, Schmittgen T: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408, 2001.
12. Boyd J, Contreras I, Kern M, Tapscott E, Downes D, Frisell W, Dohm G: Effect of a high-fat-sucrose diet on in vivo insulin receptor kinase activation. Am J Physiol 259:E111-116, 1990.
13. Kraegen EW, Clarck PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH: Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40:1397-1403, 1991.
14. Kasim-Karakas S, Vriend H, Almario R, Chow L, Goodman M: Effects of dietary carbohydrates on glucose and lipid metabolism in golden Syrian hamsters. J Lab Clin Med 128:208-213, 1996.
15. Pagliassotti M, Prach P, Koppenhafer T, Pan D: Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am J Physiol 271:R1319-R1326, 1996.
16. Yaspelkis B, Singh M, Krisan A, Collins D, Kwong C, Bernard J, Crain A: Chronic leptin treatment enhances insulin-stimulated glucose disposal in skeletal muscle of high-fat fed rodents. Life Sci 74:1801-1816, 2004.
17. Barzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L: Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest 101:1353-1361, 1998.
18. Dhahbi J, Mote P, Wingo J, Rowley B, Cao S, Walford R, Spindler S: Caloric restriction alters the feeding response of key metabolic enzyme genes. Mech Ageing Dev 122:1033-1048, 2001.
19. Poirier H, Niot I, Clement L, Guerre-Millo M, Besnard P: Development of conjugated linoleic acid (CLA)-mediated lipo- atrophic syndrome in the mouse. Biochimie 87:73-79, 2005.
20. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim H, Tange T, Okuyama H, Kasai M, Ikemoto S, Ezaki O: Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49:1534-1542, 2000.
21. Riserus U, Vessby B, Arner P, Zethelius B: Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinae- mia in obese men: close association with impaired insulin sensitivity. Diabetologia 47:1016-1019, 2004.
22. Houseknecht K, Vanden Heuvel J, Moya-Camarena S, Portocar- rero C, Peck L, Nickel K, Belury M: Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 244:678-682, 1998.
23. Henriksen E, Teachey M, Taylor Z, Jacob S, Ptock A, Krämer K, Hasselwander O: Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat. Am J Physiol Endocrinol Metab 285:E98-E105, 2003.
24. Kloting N, Kloting I: Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 332:1070-1072, 2005.
25. Mercader J, Granados N, Caimari A, Oliver P, Bonet M, Palou A: Retinol-binding protein 4 and nicotinamide phosphoribosyltrans- ferase/visfatin in rat obesity models. Horm Metab Res 40:467-472, 2008.
26. Perez-Echarri N, Perez-Matute P, Marcos-Gomez B, Martinez JA, Moreno-Aliaga MJ: Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (high-fat fed) rats. Br J Nutr 101:1059-1067, 2009.
27. Sun G, Bishop J, Khalili S, Vasdev S, Gill V, Pace D, Fitzpatrick D, Randell E, Xie YG, Zhang H: Serum visfatin concentrations are positively correlated with serum triacylglycerols and down- regulated by overfeeding in healthy young men. Am J Clin Nutr 85:399-404, 2007.
28. Shea J, Randell E, Vasdev S, Wang PP, Roebothan B, Sun G: Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men. Am J Clin Nutr 86:1310-1315, 2007.
29. Haider D, Mittermayer F, Schaller G, Artwohl M, Baumgartner- Parzer S, Prager G, Roden M, Wolzt M: Free fatty acids normalize a rosiglitazone-induced visfatin release. Am J Physiol Endocrinol Metab 291:E885-E890, 2006.
30. Swarbrick M, Stanhope K, Austrheim-Smith I, Van Loan M, Ali M, Wolfe B, Havel P: Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 51:1901-1911, 2008.
31. Sheu W, Chang T, Lee W, Ou H, Wu C, Tseng L, Lang H, Wu C, Wan C, Lee I: Effect of weight loss on proinflammatory state of mononuclear cells in obese women. Obesity (Silver Spring) 16:1033-1038, 2008.
32. de Luis D, Gonzalez Sagrado M, Conde R, Aller R, Izaola O, Romero E: Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients. Nutrition 24:517-521, 2008.
33. Krzyzanowska K, Mittermayer F, Krugluger W, Kopp H, Schernthaner G: Increase in visfatin after weight loss induced by gastroplastic surgery. Obesity (Silver Spring) 14:1886-1889, 2006.
34. Botella-Carretero J, Luque-Ramirez M, Alvarez-Blasco F, Peromingo R, San Millan J, Escobar-Morreale H: The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery. Obes Surg 18:1000-1006, 2008.
35. García-Fuentes E, García-Almeida J, García-Arnes J, García- Serrano S, Rivas-Marín J, Gallego-Perales J, Rojo-Martínez G, Garrido-Saínchez L, Bermudez-Silva F, Rodríguez de Fonseca F, Soriguer F: Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring) 15:2391-2395, 2007.
36. Kersten S: Peroxisome proliferator activated receptors and obesity. Eur J Pharmacol 440:223-234, 2002.
37. Khan S, Vanden Heuvel J: Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review). J Nutr Biochem 14:554-567, 2003.
38. Ferreí P: The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53(suppl 1):S43-S50, 2004.
39. Gurnell M: Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies. Best Pract Res Clin Endocrinol Metab 19:501-523, 2005.
40. Choi K, Ryu O, Lee K, Kim H, Seo J, Kim S, Kim N, Choi D, Baik S, Choi K: Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. Biochem Biophys Res Commun 336:747-753, 2005.
41. Hammarstedt A, Pihlajamaki J, Rotter Sopasakis V, Gogg S, Jansson P, Laakso M, Smith U: Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 91:1181-1184, 2006.
42. MacLaren R, Cui W, Cianflone K: Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 pre-adipocytes and adipocytes. Diabetes Obes Metab 9:490-497, 2007.
43. Kang K, Liu W, Albright K, Park Y, Pariza M: Trans-10, cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPAR gamma expression. Biochem Biophys Res Commun 303:795-799, 2003.
44. Takahashi Y, Kushiro M, Shinohara K, Ide T: Dietary conjugated linoleic acid reduces body fat mass and affects gene expression of proteins regulating energy metabolism in mice. Comp Biochem Physiol B Biochem Mol Biol 133:395-404, 2002.
45. Zabala A, Churruca I, Fernândez-Quintela A, Rodriguez V, Macarulla M, Martinez J, Portillo M: Trans-10, cis-12 conjugated linoleic acid inhibits lipoprotein lipase but increases the activity of lipogenic enzymes in adipose tissue from hamsters fed an atherogenic diet. Br J Nutr 95:1112-1119, 2006.
46. Kang K, Liu W, Albright KJ, Park Y, Pariza MW: Trans-10, cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPARc expression. Biochem Biophys Res Commun 303:795-799, 2003.
47. Crujeiras A, Parra D, Goyenechea E, Martinez J: Sirtuin gene expression in human mononuclear cells is modulated by caloric restriction. Eur J Clin Invest 38:672-678, 2008.
48. Haigis M, Guarente L: Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev 20:2913-2921, 2006.
49. Jiang W: Sirtuins: novel targets for metabolic disease in drug development. Biochem Biophys Res Commun 373:341-344, 2008.
50. Castan-Laurell I, Boucher J, Dray C, Daviaud D, Guigne C, Valet P: Apelin, a novel adipokine over-produced in obesity: friend or foe? Mol Cell Endocrinol 245:7-9, 2005.
51. Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, Hayakawa N, Suzuki A, Takeda J, Horikawa Y, Itoh M: The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 57:268-273, 2008.